Number 3 - MARCH 2005
COLORECTAL CANCER - ADJUVANT THERAPY

Suzuki H, Kanou Y, Ooshima H, Kawase J, Kudou J, Mizuno Y, Matsumoto S. [Trial of outpatient anti-cancer chemotherapy with infusion of 5-FU and cisplatin for advanced gastric and colorectal cancers] Gan To Kagaku Ryoho. 2005 Feb;32(2):189-93. Japanese. 

 Staritz P, Kienle P, Koch M, Benner A, von Knebel Doeberitz M, Rudi J, Weitz J. Detection of disseminated tumour cells as a potential surrogate-marker for monitoring palliative chemotherapy in colorectal cancer patients. J Exp Clin Cancer Res. 2004 Dec;23(4):633-9. 

 Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Randolph Hecht J, Mass R, Perrou B, Nelson B, Novotny WF. Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial. J Clin Oncol. 2005 Feb 28;  

Egreteau J, Boucher E, de Guibert S, Jacquelinet C, Meunier B, Boudjema K, Raoul JL. New Drugs for Colorectal Cancer (Irinotecan, Oxaliplatin, Raltitrexed) Meet Expectations in Routine Practice: A Single Center's Experience Before and After Their Introduction. Int J Gastrointest Cancer. 2005 Feb;35(1):69-76. 

Clancy TE, Dixon E, Perlis R, Sutherland FR, Zinner MJ. Hepatic arterial infusion after curative resection of colorectal cancer metastases: a meta-analysis of prospective clinical trials. J Gastrointest Surg. 2005 Feb 1;9(2):198-206.

Baxter NN, Rothenberger DA, Morris AM, Bullard KM. Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States. Dis Colon Rectum. 2005 Jan;48(1):9-15

Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):426-31. 

Turner II, Russell GB, Blackstock AW, Levine EA. Impact of neoadjuvant therapy on postoperative complications in patients undergoing resection for rectal adenocarcinoma. Am Surg. 2004 Dec;70(12):1045-9. 

Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum. 2004 Dec;47(12):2025-31. 

Keam SJ, Dunn CJ, Figgitt DP. Oxaliplatin: in operable colorectal cancer. Drugs. 2005;65(1):89-96; discussion 97-8. 

Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer. J Clin Oncol. 2004 Dec 1;22(23):4753-61.